FINNENCE ▪ THE WIRE FILE
THE WIRE · № 80682
News■ Unclear/unknown
Veeva to Host Virtual Investor Day on November 5, 2026
KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN
LAST UPDATE
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Investor day scheduling; potential strategy update but no content disclosed yet.
Event scheduled, substance still unknown
CATALYST TO WATCH
Investor day on November 5
MAIN RISK
Guidance could underwhelm investors
FULL DISPATCH
PLEASANTON, Calif., Oct. 14, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) will host its investor day virtually on Thursday, November 5, 2026. The event will begin at 1:30 p.m. PT and will conclude at approximately 3:30 p.m. PT. Veeva will broadcast the presentations live on the...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
Enliven Therapeutics Appoints Kristine Ball to Board of Directors Ahead of Planned Phase 3 Trial Initiation this Year2026-10-14 20:30 UTC
Enliven Therapeutics Appoints Kristine Ball to Board of Directors Ahead of Planned Phase 3 Trial Initiation this Year2026-10-14 20:30 UTC
→CORRELATIONshares Healthcare
Trial Demonstrates Feasibility of At-Home Subcutaneous Diuretic Therapy for Heart Failure-Associated Edema2026-10-14 20:30 UTC
Trial Demonstrates Feasibility of At-Home Subcutaneous Diuretic Therapy for Heart Failure-Associated Edema2026-10-14 20:30 UTC
→CORRELATIONshares Healthcare
The Rundown: A proposed Chicago-area healthcare merger2026-10-14 20:45 UTC
The Rundown: A proposed Chicago-area healthcare merger2026-10-14 20:45 UTC
→CORRELATIONshares Healthcare
Aurora Cannabis Reiterates Opposition to Curaleaf's Takeover Offer2026-10-14 20:25 UTC
Aurora Cannabis Reiterates Opposition to Curaleaf's Takeover Offer2026-10-14 20:25 UTC
→CORRELATIONshares Healthcare
Vanda Pharmaceuticals Provides Update on VQW-765 Clinical Development Program2026-10-14 21:00 UTC
Vanda Pharmaceuticals Provides Update on VQW-765 Clinical Development Program2026-10-14 21:00 UTC
←CORRELATIONshares Healthcare
FLSC IPO News - Biotech-focused SPAC Frazier Life Sciences Acquisition II prices $75 million IPO2026-10-14 12:32 UTC
FLSC IPO News - Biotech-focused SPAC Frazier Life Sciences Acquisition II prices $75 million IPO2026-10-14 12:32 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.